Skip to main content

Table 4 Clinical studies evaluating the prevalence of ph in esrd patients receiving renal replacement therapy

From: Renal transplant improves pulmonary hypertension in patients with end stage renal diseaseIl trapianto renale riduce l’ipertensione polmonare nei pazienti con grave insufficienza renale

Study

Definition of PH

Patients enrolled, n

Type of renal replacement therapy

Prevalence of PH (%)

Abdelwhaib et al. [14]

SPAP > 35 mm Hg

45

Hemodialysis

44

Yigla et al. [1]

SPAP > 35 mm Hg

58

Hemodialysis

39.7

  

5

Peritoneal dialysis

0

Tarrass et al. [2]

SPAP > 35 mm Hg

84

Hemodialysis

26.7

Nakhoul et al. [15]

SPAP ≥ 35 mm Hg

42

Hemodialysis

48

Havlucu et al. [3]

SPAP ≥ 35 mm Hg

25

Hemodialysis

56

Kumbar et al. [16].

SPAP ≥ 35 mm Hg

36

Peritoneal dialysis

42

Amin et al. [17].

SPAP > 35 mm Hg

51

Hemodialysis

29

Present work

SPAP ≥ 35 mm Hg

432

Hemodialysis

18.8

  

68

Peritoneal dialysis

5.9

  1. Definition of abbreviations: ESRD, end-stage renal disease; PH, pulmonary hypertension; SPAP, systolic pulmonary artery pressure.